High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Expression of 14-3-3 σ (σ) is induced in response to DNA damage, and causes cells to arrest in G 2 . By SAGE (serial analysis of gene expression) analysis, we identified σ as a gene whose expression is 7-fold lower in breast carcinoma cells than in normal breast epithelium. We verified this finding by Northern blot analysis. Remarkably, σ mRNA was undetectable in 45 of 48 primary breast carcinomas. Genetic alterations at σ such as loss of heterozygosity were rare (1/20 informative cases), and no mutations were detected (0/34). On the other hand, hypermethylation of CpG islands in the σ gene was detected in 91% (75/82) of breast tumors and was associated with lack of gene expression. Hypermethylation of σ is functionally important, because treatment of σ-non-expressing breast cancer cell lines with the drug 5-aza-2′-deoxycytidine resulted in demethylation of the gene and synthesis of σ mRNA. Breast cancer cells lacking σ expression showed increased number of chromosomal breaks and gaps when exposed to γ-irradiation. Therefore, it is possible that loss of σ expression contributes to malignant transformation by impairing the G 2 cell cycle checkpoint function, thus allowing an accumulation of genetic defects. Hypermethylation and loss of σ expression are the most consistent molecular alterations in breast cancer identified so far.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., & Paul, C. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1827 · Cited by 3,238
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citation14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Self-citationFisher, B., Dignam, J., Wolmark, N., Mamounas, E., Costantino, J., Poller, W., Fisher, E. R., Wickerham, D. L., Deutsch, M., Margolese, R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.441 · Cited by 894
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., & Baylin, S. B. (1995) · PubMed · Cited by 796
Clark, R. M., Whelan, T., Levine, M., Roberts, R., Willan, A., McCulloch, P., Lipa, M., Wilkinson, R. H., & Mahoney, L. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.22.1659 · Cited by 586
Heald, R., McLoughlin, M., & McKeon, F. (1993) · Cell · doi:10.1016/0092-8674(93)80048-j · Cited by 462
Identification of expressed genes by laser-mediated manipulation of single cells
Schüitze, K., & Lahr, G. (1998) · Nature Biotechnology · doi:10.1038/nbt0898-737 · Cited by 428
Cited by
Christman, J. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205699 · Cited by 1,525
14-3-3 proteins: A historic overview
Aitken, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.005 · Cited by 826
How do 14‐3‐3 proteins work? – Gatekeeper phosphorylation and the molecular anvil hypothesis
Yaffe, M. B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03288-4 · Cited by 660
Role of p53 in Cell Death and Human Cancers
Ozaki, T., & Nakagawara, A. (2011) · Cancers · doi:10.3390/cancers3010994 · Cited by 650
Environmental Signaling: What Embryos and Evolution Teach Us About Endocrine Disrupting Chemicals
McLachlan, J. A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.3.0432 · Cited by 608
Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes
MACKINTOSH, C. (2004) · Biochemical Journal · doi:10.1042/bj20031332 · Cited by 526
Oncogenes and Tumor Suppressor Genes
Lee, E. Y. H. P., & Muller, W. J. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003236 · Cited by 508
14-3-3 Proteins: Active Cofactors in Cellular Regulation by Serine/Threonine Phosphorylation
Tzivion, G., & Avruch, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100059200 · Cited by 491
Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays
Iacobuzio-Donahue, C. A., Maitra, A., Olsen, M., Lowe, A. W., Van Heek, N. T., Rosty, C., Walter, K., Sato, N., Parker, A., Ashfaq, R., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63911-9 · Cited by 473
Dougherty, M. K., & Morrison, D. K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01171 · Cited by 461
DNA methylation and breast carcinogenesis
Widschwendter, M., & Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205606 · Cited by 457
Kominsky, S. L., Argani, P., Korz, D., Evron, E., Raman, V., Garrett, E., Rein, A., Sauter, G., Kallioniemi, O.-P., & Sukumar, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206199 · Cited by 448
Self-citationMechanisms of transcriptional regulation by p53
Sullivan, K. D., Galbraith, M. D., Andrysik, Z., & Espinosa, J. M. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.174 · Cited by 446
Costello, J. F., & Plass, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.5.285 · Cited by 442
Hermeking, H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1230 · Cited by 437
Self-citationMaitra, A., Adsay, N. V., Argani, P., Iacobuzio-Donahue, C., De Marzo, A., Cameron, J. L., Yeo, C. J., & Hruban, R. H. (2003) · Modern Pathology · doi:10.1097/01.mp.0000086072.56290.fb · Cited by 429
“Several lines of evidence reiterate the role of 14-3-3 as a classic tumor suppressor gene in that loss of expression of 14-3-3 mRNA or protein has been reported in breast carcinomas (75), squamous cell carcinomas of the head and neck (76), primary bladder cancers (77), and hepatocellular carcinomas (78).”
BackgroundThe p53 pathway in breast cancer
Gasco, M., Shami, S., & Crook, T. (2002) · Breast Cancer Research · doi:10.1186/bcr426 · Cited by 393
Pennington, K., Chan, T., Torres, M., & Andersen, J. (2018) · Oncogene · doi:10.1038/s41388-018-0348-3 · Cited by 364
Self-citationPhosphoserine/threonine-binding domains
Yaffe, M. B., & Elia, A. E. H. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00189-7 · Cited by 354
DNA methylation regulates microRNA expression
Han, L., Witmer, P. D. W., Casey, E., Valle, D., & Sukumar, S. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.8.4486 · Cited by 332
Self-citationMHAWECH, P. (2005) · Cell Research · doi:10.1038/sj.cr.7290291 · Cited by 301
14-3-3 proteins; bringing new definitions to scaffolding
Tzivion, G., Shen, Y. H., & Zhu, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204777 · Cited by 300
“However, suppression in 14-3-3 expression has also been related to cancer (Ferguson et al., 2000; Laronga et al., 2000; Suzuki et al., 2000; Vercoutter-Edouart et al., 2001) and the validity of elevated 14-3-3 expression in neurodegenerative disease detection has been questioned (Chapman et al.,…”
BackgroundHypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer
Umbricht, C. B., Evron, E., Gabrielson, E., Ferguson, A. T., Marks, J., & Sukumar, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204438 · Cited by 291
Self-citationInsights from transgenic mouse models of ERBB2-induced breast cancer
Ursini-Siegel, J., Schade, B., Cardiff, R. D., & Muller, W. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2127 · Cited by 269
Proteomics in Early Detection of Cancer
Srinivas, P. R., Srivastava, S., Hanash, S., & Wright, G. L. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1901 · Cited by 254
Fackler, M. J., McVeigh, M., Evron, E., Garrett, E., Mehrotra, J., Polyak, K., Sukumar, S., & Argani, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11508 · Cited by 253
Self-citation14-3-3 Proteins—a focus on cancer and human disease
Wilker, E., & Yaffe, M. B. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.04.015 · Cited by 252
Genomic screen and follow‐up analysis for autistic disorder
Shao, Y., Wolpert, C. M., Raiford, K. L., Menold, M. M., Donnelly, S. L., Ravan, S. A., Bass, M. P., McClain, C., von Wendt, L., Vance, J. M., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10153 · Cited by 248
Lau, Q. C., Raja, E., Salto-Tellez, M., Liu, Q., Ito, K., Inoue, M., Putti, T. C., Loh, M., Ko, T. K., Huang, C., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0369 · Cited by 193
“There is ample evidence that histone deacetylase inhibitors cooperate with demethylating agents for more efficient restoration of gene expression through their effects on chromatin (36, 38, 39).”
BackgroundSelf-citation14-3-3 proteins and the response to abiotic and biotic stress
Roberts, M. R., Salinas, J., & Collinge, D. B. (2002) · Plant Molecular Biology · doi:10.1023/a:1021261614491 · Cited by 190
“Chan et al., 1999) and changes in expression of the 14-3-3σ gene are associated with several human cancers ( Ferguson et al., 2000; Iwata et al., 2000; Suzuki et al., 2000).”
BackgroundNeal, C. L., Yao, J., Yang, W., Zhou, X., Nguyen, N. T., Lu, J., Danes, C. G., Guo, H., Lan, K.-H., Ensor, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2765 · Cited by 175
ATM function and telomere stability
Pandita, T. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205060 · Cited by 164
Self-citationThe p53 network in head and neck cancer
Gasco, M., & Crook, T. (2003) · Oral Oncology · doi:10.1016/s1368-8375(02)00163-x · Cited by 160
“Another p53-responsive gene, 14-3-3s (s), is subject to methylation-dependent transcriptional silencing in breast and other carcinomas [12, 13].”
BackgroundRegulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
Origanti, S., Cai, S.-R., Munir, A. Z., White, L. S., & Piwnica-Worms, H. (2013) · Oncogene · doi:10.1038/onc.2012.84 · Cited by 74
Metadata
- Authors
- Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., & Sukumar, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-05-16
- Volume
- 97
- Issue
- 11
- Pages
- 6049-6054
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2140787953
- Cited by
- 444
- References
- 33
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.